Recombinetics
Private Company
Total funding raised: $54.5M
Overview
Recombinetics is a pioneering US-based biotechnology company specializing in gene editing for large animals, primarily swine and cattle. It operates a dual-market strategy, providing custom gene-edited swine models for preclinical biomedical research and developing agriculturally beneficial traits like disease resistance and heat tolerance in livestock. The company boasts a strong intellectual property portfolio, a history of industry 'firsts,' and is positioning itself for rapid growth in both the biomedical and agricultural sectors.
Technology Platform
Integrated platform for large animal gene editing, combining CRISPR/TALENs expertise, stem cell biology, serial multiplex editing, bioinformatics, and AI to create custom swine models for research and traits for livestock.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
In biomedical models, Recombinetics competes with other specialized CROs and academic centers creating animal models, but its focus on swine and gene editing is a key differentiator. In agricultural genetics, it competes with traditional animal breeding companies and larger agribiotech firms like Genus PLC, but its precision breeding via gene editing offers a speed and specificity advantage.